SHINE Medical Technologies in Monona, Wis., said it has submitted an application to the Nuclear Regulatory Commission for the establishment of a medical isotope facility in Janesville, Wis., that will produce molybdenum-99, the precursor isotope to technetium-99m. The company said it anticipates the review of its plan will take 18 months. SHINE wants to start production by 2015 and projects to create at least 150 jobs.
SHINE submits application for isotope plant to NRC
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||